Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (31-40 of 338) with videos related to

Pageof 34
Sort By:
The American Journal of Cardiology|March 15, 1997
"Cardioprotection"--not all calcium antagonists are created equal: second roundF H Messerli
European Heart Journal|January 1, 1997
Calcium antagonist controversy reassessed--'difficile est satiram non scribere'F H Messerli
Proceedings (Baylor University. Medical Center)|January 4, 2006
Antihypertensive therapy: beta-blockers and diuretics-why do physicians not always follow guidelines?F H Messerli
American Journal of Hypertension|December 1, 1996
What, if anything, is controversial about calcium antagonists?F H Messerli
Circulation|March 18, 1997
Nifedipine trialsF H Messerli
American Journal of Hypertension|April 1, 1993
Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden deathF H Messerli
Cor Et Vasa|January 1, 1993
"Cardioprotection"--not all calcium antagonists are created equalF H Messerli
Circulation|October 31, 2001
Confusing Press Releases and the PREVENT StudyF H Messerli
Annals of Internal Medicine|December 1, 1995
Case-control study, meta-analysis, and bouillabaisse: putting the calcium antagonist scare into contextF H Messerli
Postgraduate Medicine|March 1, 1984
Continuous noninvasive automatic blood pressure recording. Value and limitations in clinical practiceF H Messerli
Pageof 34

Showing results (31-40 of 338) with videos related to

Sort By:
Pageof 34
The American Journal of Cardiology|March 15, 1997
"Cardioprotection"--not all calcium antagonists are created equal: second roundF H Messerli
European Heart Journal|January 1, 1997
Calcium antagonist controversy reassessed--'difficile est satiram non scribere'F H Messerli
Proceedings (Baylor University. Medical Center)|January 4, 2006
Antihypertensive therapy: beta-blockers and diuretics-why do physicians not always follow guidelines?F H Messerli
American Journal of Hypertension|December 1, 1996
What, if anything, is controversial about calcium antagonists?F H Messerli
Circulation|March 18, 1997
Nifedipine trialsF H Messerli
American Journal of Hypertension|April 1, 1993
Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden deathF H Messerli
Cor Et Vasa|January 1, 1993
"Cardioprotection"--not all calcium antagonists are created equalF H Messerli
Circulation|October 31, 2001
Confusing Press Releases and the PREVENT StudyF H Messerli
Annals of Internal Medicine|December 1, 1995
Case-control study, meta-analysis, and bouillabaisse: putting the calcium antagonist scare into contextF H Messerli
Postgraduate Medicine|March 1, 1984
Continuous noninvasive automatic blood pressure recording. Value and limitations in clinical practiceF H Messerli
Pageof 34